 |
PDBsum entry 2qiq
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Viral protein
|
PDB id
|
|
|
|
2qiq
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.2.1.1.-
- ?????
|
|
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
E.C.2.1.1.56
- mRNA (guanine-N(7))-methyltransferase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a 5'-end (5'-triphosphoguanosine)-ribonucleoside in mRNA + S-adenosyl-L- methionine = a 5'-end (N(7)-methyl 5'-triphosphoguanosine)-ribonucleoside in mRNA + S-adenosyl-L-homocysteine
|
 |
 |
 |
 |
 |
5'-end (5'-triphosphoguanosine)-ribonucleoside in mRNA
|
+
|
S-adenosyl-L- methionine
|
=
|
5'-end (N(7)-methyl 5'-triphosphoguanosine)-ribonucleoside in mRNA
|
+
|
S-adenosyl-L-homocysteine
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
E.C.2.1.1.57
- methyltransferase cap1.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a 5'-end (N(7)-methyl 5'-triphosphoguanosine)-ribonucleoside in mRNA + S-adenosyl-L-methionine = a 5'-end (N(7)-methyl 5'-triphosphoguanosine)- (2'-O-methyl-ribonucleoside) in mRNA + S-adenosyl-L-homocysteine + H+
|
 |
 |
 |
 |
 |
5'-end (N(7)-methyl 5'-triphosphoguanosine)-ribonucleoside in mRNA
|
+
|
S-adenosyl-L-methionine
|
=
|
5'-end (N(7)-methyl 5'-triphosphoguanosine)- (2'-O-methyl-ribonucleoside) in mRNA
|
+
|
S-adenosyl-L-homocysteine
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 5:
|
 |
E.C.2.7.7.48
- RNA-directed Rna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
RNA(n) + a ribonucleoside 5'-triphosphate = RNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
RNA(n)
|
+
|
ribonucleoside 5'-triphosphate
|
=
|
RNA(n+1)
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 6:
|
 |
E.C.2.7.7.50
- mRNA guanylyltransferase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a 5'-end diphospho-ribonucleoside in mRNA + GTP + H+ = a 5'-end (5'-triphosphoguanosine)-ribonucleoside in mRNA + diphosphate
|
 |
 |
 |
 |
 |
5'-end diphospho-ribonucleoside in mRNA
|
+
|
GTP
|
+
|
H(+)
|
=
|
5'-end (5'-triphosphoguanosine)-ribonucleoside in mRNA
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 7:
|
 |
E.C.3.1.13.-
- ?????
|
|
 |
 |
 |
 |
 |
Enzyme class 8:
|
 |
E.C.3.4.19.12
- ubiquitinyl hydrolase 1.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Thiol-dependent hydrolysis of ester, thiolester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal).
|
 |
 |
 |
 |
 |
Enzyme class 9:
|
 |
E.C.3.4.22.-
- ?????
|
|
 |
 |
 |
 |
 |
Enzyme class 10:
|
 |
E.C.3.4.22.69
- Sars coronavirus main proteinase.
|
|
 |
 |
 |
 |
 |
Enzyme class 11:
|
 |
E.C.3.6.4.12
- Dna helicase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + H2O = ADP + phosphate + H+
|
 |
 |
 |
 |
 |
ATP
|
+
|
H2O
|
=
|
ADP
|
+
|
phosphate
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 12:
|
 |
E.C.3.6.4.13
- Rna helicase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + H2O = ADP + phosphate + H+
|
 |
 |
 |
 |
 |
ATP
|
+
|
H2O
|
=
|
ADP
|
+
|
phosphate
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 13:
|
 |
E.C.4.6.1.-
- ?????
|
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Bioorg Med Chem Lett
17:5876-5880
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors.
|
|
A.K.Ghosh,
K.Xi,
V.Grum-Tokars,
X.Xu,
K.Ratia,
W.Fu,
K.V.Houser,
S.C.Baker,
M.E.Johnson,
A.D.Mesecar.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Structure-based design, synthesis, and biological evaluation of a series of
peptidomimetic severe acute respiratory syndrome-coronavirus chymotrypsin-like
protease inhibitors are described. These inhibitors were designed and
synthesized based upon our X-ray crystal structure of inhibitor 1 bound to
SARS-CoV 3CLpro. Incorporation of Boc-Ser as the P(4)-ligand resulted in
enhanced SARS-CoV 3CLpro inhibitory activity. Structural analysis of the
inhibitor-bound X-ray structure revealed high binding affinity toward the enzyme.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Golda,
and
K.Pyrc
(2008).
Recent antiviral strategies against human coronavirus-related respiratory illnesses.
|
| |
Curr Opin Pulm Med,
14,
248-253.
|
 |
|
|
|
|
 |
A.K.Ghosh,
G.Gong,
V.Grum-Tokars,
D.C.Mulhearn,
S.C.Baker,
M.Coughlin,
B.S.Prabhakar,
K.Sleeman,
M.E.Johnson,
and
A.D.Mesecar
(2008).
Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors.
|
| |
Bioorg Med Chem Lett,
18,
5684-5688.
|
 |
|
|
|
|
 |
J.S.Sparks,
E.F.Donaldson,
X.Lu,
R.S.Baric,
and
M.R.Denison
(2008).
A novel mutation in murine hepatitis virus nsp5, the viral 3C-like proteinase, causes temperature-sensitive defects in viral growth and protein processing.
|
| |
J Virol,
82,
5999-6008.
|
 |
|
|
|
|
 |
U.Bacha,
J.Barrila,
S.B.Gabelli,
Y.Kiso,
L.Mario Amzel,
and
E.Freire
(2008).
Development of broad-spectrum halomethyl ketone inhibitors against coronavirus main protease 3CL(pro).
|
| |
Chem Biol Drug Des,
72,
34-49.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |